Sermorelin, a synthetic analog of growth hormone–releasing hormone (GHRH 1–29), has long attracted scientific interest due to ...

Drug discovery is shifting from static snapshots to moving pictures. Instead of inferring how medicines work from end results ...

A mouse study suggests estrogen may increase gut pain by activating specific cells, offering hints to why IBS is more common ...

ORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial ...

By Dennis Thompson HealthDay ReporterTUESDAY, Jan. 6, 2026 (HealthDay News) — A drug that mimics the female hormone progesterone might help women fight hormone-fueled breast cancer.

Not only do women get more migraines than men, but a new study shows they also experience them for a longer duration.

Estrogenic activity within a tissue is influenced by the type of estrogen and the subtype of estrogen receptor found within that tissue, [20] as well as by the distribution of cofactors and ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

Scientists have discovered that oestrogen activates pathways in the colon that trigger pain and make the female gut more sensitive to certain foods ...

Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving ...